Boothbay Fund Management, LLC Incyte Corp Call Options Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$67.18 - $84.11 $16.8 Million - $21 Million
249,400 New
249,400 $20 Million
Q3 2021

Nov 15, 2021
SELL
$68.67 - $84.02 $892,710 - $1.09 Million
-13,000 Reduced 56.77%
9,900 $681,000
Q2 2021

Aug 16, 2021
BUY
$79.87 - $87.53 $1.83 Million - $2 Million
22,900 New
22,900 $1.93 Million

Others Institutions Holding INCY

# of Institutions
644
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email